*JEFFERIES ON SAGILITY*
Initiate Buy with target price of Rs 52
Leading BPM firm focused on US Healthcare
Well positioned to deliver double-digit revenue growth
Normalization of D&A and deleveraging to spur EPS growth
Over FY25-27, expect Sagility to deliveroo 12%/40% CAGR in revenue/PAT
See normalization of D&A costs and deleveraging
Superior earnings growth outlook is likely to sustain current PE multiples
Initiate Buy with target price of Rs 52
Leading BPM firm focused on US Healthcare
Well positioned to deliver double-digit revenue growth
Normalization of D&A and deleveraging to spur EPS growth
Over FY25-27, expect Sagility to deliveroo 12%/40% CAGR in revenue/PAT
See normalization of D&A costs and deleveraging
Superior earnings growth outlook is likely to sustain current PE multiples